ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $281,000 | +1.1% | 7,981 | +32.0% | 0.01% | -9.1% |
| Q1 2022 | $278,000 | -29.8% | 6,045 | +1.2% | 0.01% | -31.2% |
| Q4 2021 | $396,000 | +6.7% | 5,973 | +0.5% | 0.02% | -5.9% |
| Q3 2021 | $371,000 | -34.3% | 5,943 | -12.9% | 0.02% | -34.6% |
| Q2 2021 | $565,000 | +29.6% | 6,822 | +3.8% | 0.03% | +13.0% |
| Q1 2021 | $436,000 | -21.9% | 6,575 | -9.6% | 0.02% | -42.5% |
| Q4 2020 | $558,000 | +58.5% | 7,272 | -11.0% | 0.04% | +29.0% |
| Q3 2020 | $352,000 | -37.0% | 8,175 | -36.8% | 0.03% | -41.5% |
| Q2 2020 | $559,000 | +50.7% | 12,943 | +0.4% | 0.05% | +35.9% |
| Q1 2020 | $371,000 | -54.6% | 12,895 | -0.0% | 0.04% | -43.5% |
| Q4 2019 | $818,000 | +108.7% | 12,896 | -7.3% | 0.07% | +86.5% |
| Q3 2019 | $392,000 | +6.5% | 13,911 | +0.2% | 0.04% | +2.8% |
| Q2 2019 | $368,000 | – | 13,887 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |